Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou can drink alcohol while taking weight loss injections such as Mounjaro or Wegovy, but the combination carries real risks worth understanding before you pour one. GLP-1 and GIP/GLP-1 medicines slow gastric emptying and alter appetite signals, which changes how your body processes alcohol — often making its effects hit faster and harder. There is no outright clinical ban, but NHS guidance and prescribers consistently advise limiting alcohol on these treatments, and several interactions warrant specific attention. These are prescription-only medicines and a prescriber reviews your full health picture before starting you on them.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The NHS patient information for tirzepatide notes that alcohol can affect blood sugar and interact with medicines in this class, and NHS guidance for both Mounjaro and Wegovy advises patients to limit alcohol while on treatment. The mechanism is straightforward: Mounjaro and Wegovy slow gastric emptying as part of how they reduce appetite. Slower stomach emptying means alcohol reaches your bloodstream more gradually at first — but once it does, the peak effect can be sharper than you are used to. People on these medicines frequently report feeling the effects of one or two drinks as strongly as they would previously have felt three or four.
There is also a nausea overlap worth knowing about. GI side effects (nausea in particular) are most common in the early weeks of treatment or after a dose step. Alcohol is independently a gastric irritant. Drink on a day when your stomach is already unsettled and both problems compound each other. A quick practical check before a social occasion: look back at how you felt in the 24 hours after your last injection. If nausea was present, that is a reasonable signal to keep the evening alcohol-free or stick to a single drink with food.
The calorie angle matters too. A large glass of wine runs to roughly 200 kcal; a pint of beer similar. GLP-1 medicines work partly by reducing total energy intake. Alcohol adds calories with no nutritional return and can lower resolve around food choices. The NHS tirzepatide guidance does not prohibit alcohol but is explicit that intake should be kept low. That is the honest clinical starting point.
Moderate, occasional drinking is very different from heavy or binge drinking on GLP-1 treatment. Three risks stand out from the clinical picture.
First, hypoglycaemia. GLP-1 medicines stimulate insulin release in a glucose-dependent way, so standalone hypoglycaemia is uncommon, but alcohol independently suppresses the liver's ability to release stored glucose. If you are also taking any other diabetes medicines, the low-blood-sugar risk stacks up further. Symptoms (shakiness, confusion, cold sweat) can be masked by alcohol intoxication. That combination is the reason prescribers take the question seriously.
Second, pancreatitis. The MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known, infrequent but potentially serious side effect of GLP-1 medicines. Alcohol is itself a recognised risk factor for acute pancreatitis. Using both together does not guarantee a problem, but it does mean any severe, persistent stomach pain that radiates to the back should prompt urgent medical attention, you should not wait it out at home. Report suspected side effects via the MHRA Yellow Card scheme.
Third, dehydration. Vomiting from GI side effects alongside significant alcohol intake is a pathway to dehydration serious enough to affect kidney function. Staying well-hydrated on these treatments is already important; alcohol works against that. If you do drink, alternating alcoholic drinks with water is basic but effective harm reduction.
None of this means you must give up alcohol permanently. The clinical consensus is that light, infrequent drinking (a single drink with a meal, not on an empty stomach) is a manageable choice for most people on these medicines. A few practical points follow from the evidence.
Eat before or alongside any alcohol. Food in the stomach changes the absorption curve. Pace yourself consciously, because your usual reference point for how much is enough is no longer reliable on GLP-1 treatment. If you want a thorough look at whether you can drink while on weight loss injections, including how different medicines compare and what the evidence says about safe limits, we cover that in full detail separately. Tell anyone you are with that you are on a medication that changes how you respond to alcohol, particularly in a situation where they might need to help you if you feel unwell.
If you are thinking about how long you will be on treatment (and therefore how long to factor in these considerations) our guide on treatment duration covers what the evidence and prescribers' guidance say. Some people also ask about the relationship between alcohol and the decision to pause or stop treatment; stopping weight loss injections is a separate clinical decision that should always involve your prescriber.
If alcohol consumption is a regular part of your life and you are unsure how to balance it with treatment, raise it openly at your consultation. A GPhC-registered prescriber reviewing your case can give specific, personalised guidance in a way that a general page cannot. For a broader picture of the available treatments and how they work, including options such as Spire weight loss injections and how they fit into the wider landscape of private treatment, the weight loss treatment overview is a useful reference. And if you want to understand how private treatment is priced and what is included, our weight loss injection prices page sets that out plainly.
The short version: light drinking is not forbidden, heavy drinking is genuinely risky, and the specifics are worth discussing with whoever is prescribing your treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.